Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis.
Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis.
复制标题
DOI:
10.1038/ng.3013
复制
发表时间:
2014-08
期刊:
影响因子:
30.8
通讯作者:
Fitzgerald, Rebecca C.
中科院分区:
文献类型:
--
作者:
Weaver, Jamie M. J.;Ross-Innes, Caryn S.;Shannon, Nicholas;Lynch, Andy G.;Forshew, Tim;Barbera, Mariagnese;Murtaza, Muhammed;Ong, Chin-Ann J.;Lao-Sirieix, Pierre;Dunning, Mark J.;Smith, Laura;Smith, Mike L.;Anderson, Charlotte L.;Carvalho, Benilton;O'Donovan, Maria;Underwood, Timothy J.;May, Andrew P.;Grehan, Nicola;Hardwick, Richard;Davies, Jim;Oloumi, Arusha;Aparicio, Sam;Caldas, Carlos;Eldridge, Matthew D.;Edwards, Paul A. W.;Rosenfeld, Nitzan;Tavare, Simon;Fitzgerald, Rebecca C.
Cancer genome sequencing studies have identified numerous driver genes but the relative timing of mutations in carcinogenesis remains unclear. The gradual progression from pre-malignant Barrett’s esophagus to esophageal adenocarcinoma (EAC) provides an ideal model to study the ordering of somatic mutations. We identified recurrently-mutated genes and assessed clonal structure using whole-genome sequencing and amplicon-resequencing of 112 EACs. We next screened a cohort of 109 biopsies from two key transition points in the development of malignancy; benign metaplastic never-dysplastic Barrett’s esophagus (NDBE, n=66), and high-grade dysplasia (HGD, n=43). Unexpectedly, the majority of recurrently mutated genes in EAC were also mutated in NDBE. Only TP53 and SMAD4 were stage-specific, confined to HGD and EAC, respectively. Finally, we applied this knowledge to identify high-risk Barrett’s esophagus in a novel non-endoscopic test. In conclusion, mutations in EAC driver genes generally occur exceptionally early in disease development with profound implications for diagnostic and therapeutic strategies.
登录
查看更多内容
影响因子:
24.5
作者:
Goh, X. Y.;Rees, J. R. E.;Fitzgerald, R. C.
通讯作者:
Fitzgerald, R. C.
影响因子:
50.3
作者:
Quante M;Bhagat G;Abrams JA;Marache F;Good P;Lee MD;Lee Y;Friedman R;Asfaha S;Dubeykovskaya Z;Mahmood U;Figueiredo JL;Kitajewski J;Shawber C;Lightdale CJ;Rustgi AK;Wang TC
通讯作者:
Wang TC
影响因子:
30.8
作者:
通讯作者:
--
影响因子:
64.8
作者:
Greaves, Mel;Maley, Carlo C.
通讯作者:
Maley, Carlo C.
影响因子:
64.5
作者:
Nik-Zainal S;Van Loo P;Wedge DC;Alexandrov LB;Greenman CD;Lau KW;Raine K;Jones D;Marshall J;Ramakrishna M;Shlien A;Cooke SL;Hinton J;Menzies A;Stebbings LA;Leroy C;Jia M;Rance R;Mudie LJ;Gamble SJ;Stephens PJ;McLaren S;Tarpey PS;Papaemmanuil E;Davies HR;Varela I;McBride DJ;Bignell GR;Leung K;Butler AP;Teague JW;Martin S;Jönsson G;Mariani O;Boyault S;Miron P;Fatima A;Langerød A;Aparicio SA;Tutt A;Sieuwerts AM;Borg Å;Thomas G;Salomon AV;Richardson AL;Børresen-Dale AL;Futreal PA;Stratton MR;Campbell PJ;Breast Cancer Working Group of the International Cancer Genome Consortium
通讯作者:
Breast Cancer Working Group of the International Cancer Genome Consortium